Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy - author's reply

L A Feagins^{1

2}

Affiliations

¹ Divisions of Gastroenterology and Hepatology, VA North Texas Healthcare System, Dallas, TX, USA.
² The University of Texas Southwestern Medical Center, Dallas, TX, USA.

Comment

L A Feagins. Aliment Pharmacol Ther. 2017 Oct.

. 2017 Oct;46(7):710.

doi: 10.1111/apt.14258.

L A Feagins^{1

2}

¹ Divisions of Gastroenterology and Hepatology, VA North Texas Healthcare System, Dallas, TX, USA.
² The University of Texas Southwestern Medical Center, Dallas, TX, USA.

No abstract available

Comment on

Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality.
Krill T, Brown G, Weideman RA, Cipher DJ, Spechler SJ, Brilakis E, Feagins LA. Krill T, et al. Aliment Pharmacol Ther. 2017 Jul;46(2):183-192. doi: 10.1111/apt.14121. Epub 2017 May 9. Aliment Pharmacol Ther. 2017. PMID: 28488370
Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy.
Ponzetto A, Figura N. Ponzetto A, et al. Aliment Pharmacol Ther. 2017 Oct;46(7):709. doi: 10.1111/apt.14244. Aliment Pharmacol Ther. 2017. PMID: 28880447 No abstract available.